https://www.selleckchem.com/pr....oducts/guanosine-5-m
Bridging anticoagulation increased the postoperative incidence of major bleeding events (8% vs. 1%; p 0.001) as well as minor bleeding events (14% vs. 5%; p 0.001). Thromboembolic events were equally rare in both groups (1% vs. 2%; p = 0.45). No effect on mortality was observed (1.5% vs. 1.9%). Independent risk factors of major postoperative bleeding were full-therapeutic dose of LMWH, renal insufficiency, and the procedure-specific bleeding risk. Perioperative bridging anticoagulation, especial
Like
Comment
Share
